Author:
de B. Moreira Thiago Luiz,Barbosa Artur F.S.,Veiga-Santos Phercyles,Henriques Cristina,Henriques-Pons Andrea,Galdino Suely L.,de Lima Maria do Carmo A.,Pitta Ivan da R.,de Souza Wanderley,de Carvalho Tecia Maria U.
Funder
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Financiadora de Estudos e Projetos (FINEP)
Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference15 articles.
1. Two approaches to discovering and developing new drugs for Chagas disease;Mckerrow;Mem Inst Oswaldo Cruz,2009
2. Imidazolidines as new anti-Trypanosoma cruzi agents: biological evaluation and structure–activity relationships;Caterina;Bioorg Med Chem,2008
3. Trypanosoma cruzi antioxidant enzymes as virulence factors in Chagas disease;Piacenza;Antioxid Redox Signal,2012
4. Actions of a proline analogue, l-thiazolidine-4-carboxylic acid (T4C), on Trypanosoma cruzi;Magdaleno;PLoS ONE,2009
5. Growth and differentiation in Trypanosoma cruzi. I. Origin of metacyclic trypomastigotes in liquid media;Camargo;Rev Inst Med Trop Sao Paulo,1964
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献